ALFA Finder| Management target | Revenue 20.0% FY27 |
|---|
| Revenue growth | 20% YoY guidance for FY27. |
|---|---|
| Margins | MedTech EBITDA at 20% vs Renewables at 11%. |
| Order book | 3000 Cr in LED/Renewables; 500+ dialysis machines. |
| Demand visibility | Strong via 3000 Cr order book and National Sickle Cell Mission. |
| Management confidence | High; cited 'monopolistic' technologies and strong government partnerships. |
Growth
Topline reached 280 Cr with 32 Cr PAT. Management expects H2 to outperform H1 due to seasonal B2G cycles.
Outlook
Guided for 1550 Cr revenue in FY27. Long-term target of 2000 Cr+ by FY28 with 10-11% PAT margins.
Risks
Regulatory delays for ICMR/CDSCO approvals on new MedTech products and high promoter shareholding requiring dilution.
Earnings Call Transcript filed with BSE, NSE: KRATOSENER. Summary written with AI assistance from the document.
Lords Mark Industries Ltd: key numbers
- Share price
- ₹80.05
- Market cap
- ₹3,415 Cr
- Revenue (annual)
- ₹684.8 Cr
- Net profit (annual)
- ₹48.59 Cr
- P/E (TTM)
- 40.9×Sector 20.8×
- Promoter holding
- 75.30%-4.54% QoQ
- FII holding
- 1.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lords Mark Industries Ltd
All →Lords Mark Industries Board Meeting Date
Lord's Mark Industries Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Lords Mark Industries Business Update
Lord's Mark showcased defence products from its investee Brahamastra, including BRAK RT and TRC-1. The promotional release discloses no orders, revenue, or quantified investment amount.
Lords Mark Industries Preferential Issue
Lord's Mark Industries seeks approval for a promoter loan of up to ₹100 Crore convertible into equity via postal ballot. E-voting closes November 25, 2026.
Lords Mark Industries Debt & Borrowing: ₹100 Cr
Lord's Mark Industries approved a ₹100 Crore convertible loan from promoter MD Upadhyay. Shareholder approval will be sought via postal ballot by November 27, 2026.
- Value
- ₹100.0 Cr
Lords Mark Industries Capacity Expansion
Lord’s Mark Industries completed its Silvassa manufacturing capacity expansion ahead of schedule. The company also secured US FDA registration for over 200 surgical and hygiene products.
Lords Mark Industries Fund Raise of ₹100 Cr
Lord's Mark Industries will hold a board meeting on October 23, 2026, to consider raising a Rs. 100 Crore unsecured convertible loan from its promoter.
- Value
- ₹100.0 Cr